A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its marketed PD-1 inhibitor in the challenging field of ...

Combination therapy with a nonsteroidal mineralocorticoid receptor antagonist and an SGLT2 inhibitor reduced albuminuria more ...

Burkitt's lymphoma is a highly aggressive blood cancer that primarily affects children and young adults. It is driven by a ...

By improving BP control and treatment adherence, use of fixed-dose combination therapies is expected to drive down CV events ...

Please provide your email address to receive an email when new articles are posted on . In patients with pulmonary arterial hypertension, many initially receive just one drug of the combination ...

Sustained long-term safety data for tildrakizumab strengthens the positioning of IL-23 inhibitors as a preferred choice, especially for patients with comorbidities or a history of infection, and ...

CSPC Pharmaceutical Group ( ($HK:1093) ) has shared an announcement. CSPC Pharmaceutical Group has received approval from China’s National Medical ...

The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with reassurance, ...

A combination of two widely available drugs could significantly reduce deaths from heart attacks, a study has found. New evidence shows combining statins with ezetimibe immediately is more effective ...